Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 2, Pages 75
Publisher
MDPI AG
Online
2021-01-22
DOI
10.3390/vaccines9020075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets
- (2020) Jørgen de Jonge et al. npj Vaccines
- Immune Responses to Avian Influenza Viruses
- (2019) Marios Koutsakos et al. JOURNAL OF IMMUNOLOGY
- Development of a Universal Influenza Vaccine
- (2019) Leonardo D. Estrada et al. JOURNAL OF IMMUNOLOGY
- Current and future influenza vaccines
- (2019) Seiya Yamayoshi et al. NATURE MEDICINE
- The 1918 influenza pandemic: 100 years of questions answered and unanswered
- (2019) Jeffery K. Taubenberger et al. Science Translational Medicine
- Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood
- (2019) Béatrice Laupèze et al. VACCINE
- LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice
- (2019) E. Valli et al. Scientific Reports
- Effective Immunization of Older Adults Against Seasonal Influenza
- (2018) William Schaffner et al. AMERICAN JOURNAL OF MEDICINE
- MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine
- (2018) Eun-Ju Ko et al. ANTIVIRAL RESEARCH
- Assessment of human-to-human transmissibility of avian influenza A(H7N9) virus across five waves by analyzing clusters of case-patients in mainland China, 2013–2017
- (2018) Xiling Wang et al. CLINICAL INFECTIOUS DISEASES
- Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease
- (2018) Patricia P. Lopes et al. JOURNAL OF VIROLOGY
- Chasing Seasonal Influenza — The Need for a Universal Influenza Vaccine
- (2018) Catharine I. Paules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
- (2018) Dennis Christensen et al. Frontiers in Immunology
- Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
- (2018) Sarah Schillie et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial
- (2018) Stéphane Pillet et al. npj Vaccines
- A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking
- (2018) Jeffrey A. Gelfand et al. FASEB JOURNAL
- Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant
- (2018) Yan Cao et al. Nature Communications
- Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis
- (2018) Yu-Ju Lin et al. Scientific Reports
- The influenza virus hemagglutinin head evolves faster than the stalk domain
- (2018) Ericka Kirkpatrick et al. Scientific Reports
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
- (2018) John D. Clements et al. mSphere
- The adjuvant GLA-AF enhances human intradermal vaccine responses
- (2018) Darrick Carter et al. Science Advances
- AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
- (2018) Surender Khurana et al. npj Vaccines
- Host and viral determinants of influenza A virus species specificity
- (2018) Jason S. Long et al. NATURE REVIEWS MICROBIOLOGY
- Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
- (2018) Harm HogenEsch et al. npj Vaccines
- Evolution of Influenza A Virus by Mutation and Re-Assortment
- (2017) Wenhan Shao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine
- (2017) Kaitlyn Morse et al. JOURNAL OF IMMUNOLOGY
- A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus
- (2017) Nicholas C. Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses
- (2017) Hyeok-Il Kwon et al. JOURNAL OF VIROLOGY
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody
- (2017) Donald D. Raymond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
- (2017) Gale Smith et al. VACCINE
- Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets
- (2017) Xiangjie Sun et al. VIROLOGY
- Antibody Immunity Induced by H7N9 Avian Influenza Vaccines: Evaluation Criteria, Affecting Factors, and Implications for Rational Vaccine Design
- (2017) Zenglei Hu et al. Frontiers in Microbiology
- Constraints, Drivers, and Implications of Influenza A Virus Reassortment
- (2017) Anice C. Lowen Annual Review of Virology
- AS03- and MF59-Adjuvanted Influenza Vaccines in Children
- (2017) Amanda L. Wilkins et al. Frontiers in Immunology
- A conserved TLR5 binding and activation hot spot on flagellin
- (2017) Wan Seok Song et al. Scientific Reports
- A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
- (2017) Neal Van Hoeven et al. Scientific Reports
- 2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
- (2016) Richard K. Zimmerman et al. CLINICAL INFECTIOUS DISEASES
- Adjuvant system AS01: helping to overcome the challenges of modern vaccines
- (2016) Arnaud M. Didierlaurent et al. Expert Review of Vaccines
- An overview of the regulation of influenza vaccines in the United States
- (2016) Jerry P. Weir et al. Influenza and Other Respiratory Viruses
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
- (2016) Ivan Fan-Ngai Hung et al. LANCET INFECTIOUS DISEASES
- Universal influenza vaccines: Shifting to better vaccines
- (2016) Francesco Berlanda Scorza et al. VACCINE
- Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
- (2016) Pieter T. de Boer et al. VALUE IN HEALTH
- From discovery to licensure, the Adjuvant System story
- (2016) Nathalie Garçon et al. Human Vaccines & Immunotherapeutics
- The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan
- (2016) Roly Gosling et al. PLOS MEDICINE
- Alum: an old dog with new tricks
- (2016) Yumei Wen et al. Emerging Microbes & Infections
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- Molecular epidemiology of H5N1 avian influenza
- (2016) Y. GUAN et al. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- Pandemic influenza - including a risk assessment of H5N1
- (2016) J.K. TAUBENBERGER et al. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
- (2015) Lisa A. Jackson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses
- (2015) Peter H. Goff et al. JOURNAL OF VIROLOGY
- Effective and lesion-free cutaneous influenza vaccination
- (2015) Ji Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers
- (2015) Woo Jung Kim et al. VACCINE
- Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
- (2015) Freek Cox et al. Virology Journal
- H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
- (2015) Hang Xie et al. Scientific Reports
- Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future
- (2015) Yotam Levin et al. Human Vaccines & Immunotherapeutics
- Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
- (2015) Ernest Milián et al. Biomed Research International
- Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge
- (2015) Freek Cox et al. PLoS One
- Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
- (2015) Rebecca J. Cox et al. PLoS One
- Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
- (2014) Mark J. Mulligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial
- (2014) Linda McAllister et al. LANCET
- Pandemic Preparedness and Response — Lessons from the H1N1 Influenza of 2009
- (2014) Harvey V. Fineberg NEW ENGLAND JOURNAL OF MEDICINE
- Correction: MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2014) Angelika Banzhoff et al. PLoS One
- GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
- (2014) Christopher H. Clegg et al. PLoS One
- Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
- (2014) Terry Nolan et al. VACCINE
- A micro-sterile inflammation array as an adjuvant for influenza vaccines
- (2014) Ji Wang et al. Nature Communications
- Receptor binding and pH stability — How influenza A virus hemagglutinin affects host-specific virus infection
- (2013) Caroline M. Mair et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical vaccine development for H5N1 influenza
- (2013) Christopher H Clegg et al. Expert Review of Vaccines
- Near-Infrared Laser Adjuvant for Influenza Vaccine
- (2013) Satoshi Kashiwagi et al. PLoS One
- CD4+ T Cell Autoimmunity to Hypocretin/Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy
- (2013) A. K. De la Herran-Arita et al. Science Translational Medicine
- Vaccine adjuvant formulations: A pharmaceutical perspective
- (2013) Luis A. Brito et al. SEMINARS IN IMMUNOLOGY
- H5N1 vaccines in humans
- (2013) Mariana Baz et al. VIRUS RESEARCH
- Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
- (2013) E. Miller et al. BMJ-British Medical Journal
- Emulsion based vaccine adjuvants
- (2013) Derek T O'Hagan et al. Human Vaccines & Immunotherapeutics
- Global alert to avian influenza virus infection: From H5N1 to H7N9
- (2013) Yong Poovorawan et al. Pathogens and Global Health
- Improved Efficacy of Dendritic Cell-Based Immunotherapy by Cutaneous Laser Illumination
- (2012) X. Chen et al. CLINICAL CANCER RESEARCH
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
- (2012) Nathalie Garçon et al. Expert Review of Vaccines
- The history of MF59®adjuvant: a phoenix that arose from the ashes
- (2012) Derek T O’Hagan et al. Expert Review of Vaccines
- Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin
- (2012) Els F. Halff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine
- (2012) Simona Di Mario et al. LANCET ONCOLOGY
- AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
- (2012) Hanna Nohynek et al. PLoS One
- High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants
- (2012) Xinyuan Chen et al. VACCINE
- Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects
- (2012) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
- (2012) Giancarlo Icardi et al. Human Vaccines & Immunotherapeutics
- The rationale for quadrivalent influenza vaccines
- (2012) Christopher S. Ambrose et al. Human Vaccines & Immunotherapeutics
- Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
- (2011) Fang Han et al. ANNALS OF NEUROLOGY
- Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
- (2011) Nathalie Garçon et al. BIODRUGS
- A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
- (2011) Austin Pantel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation
- (2011) Karin Lövgren Bengtsson et al. Expert Review of Vaccines
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Antigen depot is not required for alum adjuvanticity
- (2011) Sharon Hutchison et al. FASEB JOURNAL
- Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010
- (2011) et al. Influenza and Other Respiratory Viruses
- GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
- (2011) Hayedeh Behzad et al. JOURNAL OF INFECTIOUS DISEASES
- Alum adjuvant: some of the tricks of the oldest adjuvant
- (2011) M. Kool et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
- (2011) Theodore F. Tsai et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes
- (2011) Ida Rosenkrands et al. VACCINE
- Devices for intradermal vaccination
- (2011) Elsa E. Kis et al. VACCINE
- Mode of action of adjuvants: Implications for vaccine safety and design
- (2010) Béatris Mastelic et al. BIOLOGICALS
- Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
- (2010) Jeffery K. Taubenberger et al. Cell Host & Microbe
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Influenza A Virus Polymerase: Structural Insights into Replication and Host Adaptation Mechanisms
- (2010) Stéphane Boivin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
- (2010) Philippe Moris et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Flagellin as an Adjuvant: Cellular Mechanisms and Potential
- (2010) S. B. Mizel et al. JOURNAL OF IMMUNOLOGY
- Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
- (2010) Joanne M. Langley et al. JOURNAL OF INFECTIOUS DISEASES
- Needle-free influenza vaccination
- (2010) Jean-Pierre Amorij et al. LANCET INFECTIOUS DISEASES
- Influenza Vaccines: From Surveillance Through Production to Protection
- (2010) Pritish K. Tosh et al. MAYO CLINIC PROCEEDINGS
- A Novel Laser Vaccine Adjuvant Increases the Motility of Antigen Presenting Cells
- (2010) Xinyuan Chen et al. PLoS One
- Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
- (2010) Bao-Zhong Wang et al. PLoS One
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Structure, biological functions and applications of the AB5 toxins
- (2010) Travis Beddoe et al. TRENDS IN BIOCHEMICAL SCIENCES
- Non-toxic derivatives of LT as potent adjuvants
- (2010) Vanusa P. da Hora et al. VACCINE
- Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data
- (2009) Geert Leroux-Roels EXPERT OPINION ON BIOLOGICAL THERAPY
- Geographic Dependence, Surveillance, and Origins of the 2009 Influenza A (H1N1) Virus
- (2009) Vladimir Trifonov et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ISCOMs and ISCOMATRIX™
- (2009) Hong-Xiang Sun et al. VACCINE
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
- (2009) Christian Herzog et al. VACCINE
- Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
- (2009) Daniel Wai-Sing Chu et al. VACCINE
- Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
- (2009) Tino F. Schwarz et al. VACCINE
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
- (2009) Isabel Leroux-Roels et al. VACCINE
- The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
- (2008) Luigi Franchi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Pandemic H5N1 influenza vaccine development: an update
- (2008) Hana M El Sahly et al. Expert Review of Vaccines
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season
- (2008) Edward A. Belongia et al. JOURNAL OF INFECTIOUS DISEASES
- Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses
- (2008) B.-Z. Wang et al. JOURNAL OF VIROLOGY
- Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
- (2008) Lance C Jennings et al. LANCET INFECTIOUS DISEASES
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
- Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses
- (2008) Filippo Ansaldi et al. VACCINE
- The biology of influenza viruses
- (2008) Nicole M. Bouvier et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started